Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: June 30, 2022

Hikma Intl Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HIKMA INTL PHARMS, and when can generic versions of HIKMA INTL PHARMS drugs launch?

HIKMA INTL PHARMS has forty-five approved drugs.

There are five US patents protecting HIKMA INTL PHARMS drugs.

Summary for Hikma Intl Pharms

US Patents:	5
Tradenames:	33
Ingredients:	32
NDAs:	45

Drugs and US Patents for Hikma Intl Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma Intl Pharms	AMINOPHYLLINE	aminophylline	TABLET;ORAL	085003-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Hikma Intl Pharms	NAPROXEN	naproxen	TABLET;ORAL	076494-003	Jan 14, 2004		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Hikma Intl Pharms	LISINOPRIL	lisinopril	TABLET;ORAL	076063-005	Jul 1, 2002		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Hikma Intl Pharms	LISINOPRIL	lisinopril	TABLET;ORAL	076063-003	Jul 1, 2002		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Hikma Intl Pharms	DOXYCYCLINE HYCLATE	doxycycline hyclate	CAPSULE;ORAL	062396-001	May 7, 1984	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for HIKMA INTL PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	0.6 mg	➤ Subscribe	2016-06-10

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

McKinsey

Johnson and Johnson

Moodys

Boehringer Ingelheim

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.